{"entity":{"type":"insider","cik":"0001494892","url":"/insider/0001494892","json_url":"/insider/0001494892.json","name":"Haluska Frank","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":21,"n_filings":20,"first":"2012-02-23","last":"2016-03-22","span_basis":"filed_date"},"name_variants":[{"name":"Haluska Frank","source":"filing","n_filings":20,"first_seen":"2012-02-23","last_seen":"2016-03-22"}],"transactions":[{"id":2538917,"accession":"0000884731-16-000019","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000884731-16-000019","line_url":"/filing/0000884731-16-000019#line-2","is_derivative":false,"issuer_cik":"0000884731","issuer_name":"ARIAD PHARMACEUTICALS INC","issuer_ticker":"ARIA","issuer_name_source":null,"issuer_url":"/issuer/0000884731","owner_cik":"0001494892","owner_name":"Haluska Frank","owner_display_name":"Haluska Frank","owner_url":"/insider/0001494892","role":"Officer (SVP, Clinical R&D, CMO)","role_mark":"O","role_mark_label":"Officer (SVP, Clinical R&D, CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Clinical R&D, CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3575.0,"shares_display":"3,575","price_per_share":6.4661,"price_display":"6.47","price_state":"stated","total_value":23116.3075,"total_display":"23,116.31","total_whole":"23,116","shares_owned_after":147011.0,"shares_owned_after_display":"147,011","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-03-21","filed_date":"2016-03-22","scope":"insider"},{"id":3322985,"accession":"0001127602-16-044954","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-16-044954","line_url":"/filing/0001127602-16-044954#line-2","is_derivative":false,"issuer_cik":"0000884731","issuer_name":"ARIAD PHARMACEUTICALS INC","issuer_ticker":"ARIA","issuer_name_source":null,"issuer_url":"/issuer/0000884731","owner_cik":"0001494892","owner_name":"Haluska Frank","owner_display_name":"Haluska Frank","owner_url":"/insider/0001494892","role":"Officer (SVP, Clinical R&D, CMO)","role_mark":"O","role_mark_label":"Officer (SVP, Clinical R&D, CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Clinical R&D, CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10588.0,"shares_display":"10,588","price_per_share":6.1138,"price_display":"6.11","price_state":"stated","total_value":64732.9144,"total_display":"64,732.91","total_whole":"64,733","shares_owned_after":144086.0,"shares_owned_after_display":"144,086","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-03-03","filed_date":"2016-03-03","scope":"insider"},{"id":2658281,"accession":"0001127602-16-039308","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-16-039308","line_url":"/filing/0001127602-16-039308#line-2","is_derivative":false,"issuer_cik":"0000884731","issuer_name":"ARIAD PHARMACEUTICALS INC","issuer_ticker":"ARIA","issuer_name_source":null,"issuer_url":"/issuer/0000884731","owner_cik":"0001494892","owner_name":"Haluska Frank","owner_display_name":"Haluska Frank","owner_url":"/insider/0001494892","role":"Officer (SVP, Clinical R&D, CMO)","role_mark":"O","role_mark_label":"Officer (SVP, Clinical R&D, CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Clinical R&D, CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16133.0,"shares_display":"16,133","price_per_share":4.8092,"price_display":"4.81","price_state":"stated","total_value":77586.8236,"total_display":"77,586.82","total_whole":"77,587","shares_owned_after":135424.0,"shares_owned_after_display":"135,424","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-01","filed_date":"2016-02-03","scope":"insider"},{"id":8666137,"accession":"0001127602-15-027731","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-15-027731","line_url":"/filing/0001127602-15-027731#line-2","is_derivative":false,"issuer_cik":"0000884731","issuer_name":"ARIAD PHARMACEUTICALS INC","issuer_ticker":"ARIA","issuer_name_source":null,"issuer_url":"/issuer/0000884731","owner_cik":"0001494892","owner_name":"Haluska Frank","owner_display_name":"Haluska Frank","owner_url":"/insider/0001494892","role":"Officer (SVP, Clinical R&D, CMO)","role_mark":"O","role_mark_label":"Officer (SVP, Clinical R&D, CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Clinical R&D, CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5500.0,"shares_display":"5,500","price_per_share":6.455,"price_display":"6.46","price_state":"stated","total_value":35502.5,"total_display":"35,502.50","total_whole":"35,503","shares_owned_after":122224.0,"shares_owned_after_display":"122,224","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-09-28","filed_date":"2015-09-28","scope":"insider"},{"id":8694881,"accession":"0001127602-15-022972","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-15-022972","line_url":"/filing/0001127602-15-022972#line-2","is_derivative":false,"issuer_cik":"0000884731","issuer_name":"ARIAD PHARMACEUTICALS INC","issuer_ticker":"ARIA","issuer_name_source":null,"issuer_url":"/issuer/0000884731","owner_cik":"0001494892","owner_name":"Haluska Frank","owner_display_name":"Haluska Frank","owner_url":"/insider/0001494892","role":"Officer (SVP, Clinical R&D, CMO)","role_mark":"O","role_mark_label":"Officer (SVP, Clinical R&D, CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Clinical R&D, CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4400.0,"shares_display":"4,400","price_per_share":8.5397,"price_display":"8.54","price_state":"stated","total_value":37574.68,"total_display":"37,574.68","total_whole":"37,575","shares_owned_after":117724.0,"shares_owned_after_display":"117,724","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-07-16","filed_date":"2015-07-16","scope":"insider"},{"id":8091979,"accession":"0001127602-15-012345","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001127602-15-012345","line_url":"/filing/0001127602-15-012345#line-4","is_derivative":false,"issuer_cik":"0000884731","issuer_name":"ARIAD PHARMACEUTICALS INC","issuer_ticker":"ARIA","issuer_name_source":null,"issuer_url":"/issuer/0000884731","owner_cik":"0001494892","owner_name":"Haluska Frank","owner_display_name":"Haluska Frank","owner_url":"/insider/0001494892","role":"Officer (SVP, Clinical R&D, CMO)","role_mark":"O","role_mark_label":"Officer (SVP, Clinical R&D, CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Clinical R&D, CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3300.0,"shares_display":"3,300","price_per_share":8.5541,"price_display":"8.55","price_state":"stated","total_value":28228.53,"total_display":"28,228.53","total_whole":"28,229","shares_owned_after":114124.0,"shares_owned_after_display":"114,124","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-23","filed_date":"2015-03-23","scope":"insider"},{"id":8091977,"accession":"0001127602-15-012345","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001127602-15-012345","line_url":"/filing/0001127602-15-012345#line-3","is_derivative":false,"issuer_cik":"0000884731","issuer_name":"ARIAD PHARMACEUTICALS INC","issuer_ticker":"ARIA","issuer_name_source":null,"issuer_url":"/issuer/0000884731","owner_cik":"0001494892","owner_name":"Haluska Frank","owner_display_name":"Haluska Frank","owner_url":"/insider/0001494892","role":"Officer (SVP, Clinical R&D, CMO)","role_mark":"O","role_mark_label":"Officer (SVP, Clinical R&D, CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Clinical R&D, CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3575.0,"shares_display":"3,575","price_per_share":8.8488,"price_display":"8.85","price_state":"stated","total_value":31634.46,"total_display":"31,634.46","total_whole":"31,634","shares_owned_after":111424.0,"shares_owned_after_display":"111,424","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-20","filed_date":"2015-03-23","scope":"insider"},{"id":8780117,"accession":"0001127602-15-004354","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-15-004354","line_url":"/filing/0001127602-15-004354#line-2","is_derivative":false,"issuer_cik":"0000884731","issuer_name":"ARIAD PHARMACEUTICALS INC","issuer_ticker":"ARIA","issuer_name_source":null,"issuer_url":"/issuer/0000884731","owner_cik":"0001494892","owner_name":"Haluska Frank","owner_display_name":"Haluska Frank","owner_url":"/insider/0001494892","role":"Officer (SVP, Clinical R&D, CMO)","role_mark":"O","role_mark_label":"Officer (SVP, Clinical R&D, CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Clinical R&D, CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16134.0,"shares_display":"16,134","price_per_share":6.3287,"price_display":"6.33","price_state":"stated","total_value":102107.2458,"total_display":"102,107.25","total_whole":"102,107","shares_owned_after":108499.0,"shares_owned_after_display":"108,499","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-02","filed_date":"2015-02-04","scope":"insider"},{"id":6792499,"accession":"0001127602-14-013999","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-14-013999","line_url":"/filing/0001127602-14-013999#line-2","is_derivative":false,"issuer_cik":"0000884731","issuer_name":"ARIAD PHARMACEUTICALS INC","issuer_ticker":"ARIA","issuer_name_source":null,"issuer_url":"/issuer/0000884731","owner_cik":"0001494892","owner_name":"Haluska Frank","owner_display_name":"Haluska Frank","owner_url":"/insider/0001494892","role":"Officer (SVP, Clinical R&D, CMO)","role_mark":"O","role_mark_label":"Officer (SVP, Clinical R&D, CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Clinical R&D, CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3400.0,"shares_display":"3,400","price_per_share":8.2106,"price_display":"8.21","price_state":"stated","total_value":27916.04,"total_display":"27,916.04","total_whole":"27,916","shares_owned_after":104296.0,"shares_owned_after_display":"104,296","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-04-02","filed_date":"2014-04-03","scope":"insider"},{"id":6859938,"accession":"0001127602-14-012525","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001127602-14-012525","line_url":"/filing/0001127602-14-012525#line-4","is_derivative":false,"issuer_cik":"0000884731","issuer_name":"ARIAD PHARMACEUTICALS INC","issuer_ticker":"ARIA","issuer_name_source":null,"issuer_url":"/issuer/0000884731","owner_cik":"0001494892","owner_name":"Haluska Frank","owner_display_name":"Haluska Frank","owner_url":"/insider/0001494892","role":"Officer (SVP, Clinical R&D, CMO)","role_mark":"O","role_mark_label":"Officer (SVP, Clinical R&D, CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Clinical R&D, CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2400.0,"shares_display":"2,400","price_per_share":7.8919,"price_display":"7.89","price_state":"stated","total_value":18940.56,"total_display":"18,940.56","total_whole":"18,941","shares_owned_after":99196.0,"shares_owned_after_display":"99,196","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-21","filed_date":"2014-03-21","scope":"insider"},{"id":4862786,"accession":"0001127602-13-035383","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-13-035383","line_url":"/filing/0001127602-13-035383#line-2","is_derivative":false,"issuer_cik":"0000884731","issuer_name":"ARIAD PHARMACEUTICALS INC","issuer_ticker":"ARIA","issuer_name_source":null,"issuer_url":"/issuer/0000884731","owner_cik":"0001494892","owner_name":"Haluska Frank","owner_display_name":"Haluska Frank","owner_url":"/insider/0001494892","role":"Officer (SVP, Clinical R&D, CMO)","role_mark":"O","role_mark_label":"Officer (SVP, Clinical R&D, CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Clinical R&D, CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5100.0,"shares_display":"5,100","price_per_share":5.14,"price_display":"5.14","price_state":"stated","total_value":26214.0,"total_display":"26,214.00","total_whole":"26,214","shares_owned_after":91157.0,"shares_owned_after_display":"91,157","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-12-19","filed_date":"2013-12-20","scope":"insider"},{"id":5560337,"accession":"0001127602-13-023099","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-13-023099","line_url":"/filing/0001127602-13-023099#line-1","is_derivative":false,"issuer_cik":"0000884731","issuer_name":"ARIAD PHARMACEUTICALS INC","issuer_ticker":"ARIA","issuer_name_source":null,"issuer_url":"/issuer/0000884731","owner_cik":"0001494892","owner_name":"Haluska Frank","owner_display_name":"Haluska Frank","owner_url":"/insider/0001494892","role":"Officer (SVP, Clinical R&D, CMO)","role_mark":"O","role_mark_label":"Officer (SVP, Clinical R&D, CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Clinical R&D, CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6400.0,"shares_display":"6,400","price_per_share":19.7878,"price_display":"19.79","price_state":"stated","total_value":126641.92,"total_display":"126,641.92","total_whole":"126,642","shares_owned_after":83507.0,"shares_owned_after_display":"83,507","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-07-18","filed_date":"2013-07-18","scope":"insider"},{"id":5498834,"accession":"0001127602-13-013311","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-13-013311","line_url":"/filing/0001127602-13-013311#line-2","is_derivative":false,"issuer_cik":"0000884731","issuer_name":"ARIAD PHARMACEUTICALS INC","issuer_ticker":"ARIA","issuer_name_source":null,"issuer_url":"/issuer/0000884731","owner_cik":"0001494892","owner_name":"Haluska Frank","owner_display_name":"Haluska Frank","owner_url":"/insider/0001494892","role":"Officer (SVP, Clinical R&D, CMO)","role_mark":"O","role_mark_label":"Officer (SVP, Clinical R&D, CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Clinical R&D, CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3400.0,"shares_display":"3,400","price_per_share":18.041,"price_display":"18.04","price_state":"stated","total_value":61339.4,"total_display":"61,339.40","total_whole":"61,339","shares_owned_after":73907.0,"shares_owned_after_display":"73,907","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-04-02","filed_date":"2013-04-03","scope":"insider"},{"id":5438359,"accession":"0001127602-13-012013","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-13-012013","line_url":"/filing/0001127602-13-012013#line-2","is_derivative":false,"issuer_cik":"0000884731","issuer_name":"ARIAD PHARMACEUTICALS INC","issuer_ticker":"ARIA","issuer_name_source":null,"issuer_url":"/issuer/0000884731","owner_cik":"0001494892","owner_name":"Haluska Frank","owner_display_name":"Haluska Frank","owner_url":"/insider/0001494892","role":"Officer (SVP, Clinical R&D, CMO)","role_mark":"O","role_mark_label":"Officer (SVP, Clinical R&D, CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Clinical R&D, CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5333.0,"shares_display":"5,333","price_per_share":18.8772,"price_display":"18.88","price_state":"stated","total_value":100672.1076,"total_display":"100,672.11","total_whole":"100,672","shares_owned_after":68807.0,"shares_owned_after_display":"68,807","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-25","filed_date":"2013-03-26","scope":"insider"},{"id":5318983,"accession":"0001127602-13-011839","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-13-011839","line_url":"/filing/0001127602-13-011839#line-2","is_derivative":false,"issuer_cik":"0000884731","issuer_name":"ARIAD PHARMACEUTICALS INC","issuer_ticker":"ARIA","issuer_name_source":null,"issuer_url":"/issuer/0000884731","owner_cik":"0001494892","owner_name":"Haluska Frank","owner_display_name":"Haluska Frank","owner_url":"/insider/0001494892","role":"Officer (SVP, Clinical R&D, CMO)","role_mark":"O","role_mark_label":"Officer (SVP, Clinical R&D, CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Clinical R&D, CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2400.0,"shares_display":"2,400","price_per_share":19.4558,"price_display":"19.46","price_state":"stated","total_value":46693.92,"total_display":"46,693.92","total_whole":"46,694","shares_owned_after":60807.0,"shares_owned_after_display":"60,807","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-22","filed_date":"2013-03-22","scope":"insider"},{"id":3116057,"accession":"0001127602-12-015940","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-12-015940","line_url":"/filing/0001127602-12-015940#line-2","is_derivative":false,"issuer_cik":"0000884731","issuer_name":"ARIAD PHARMACEUTICALS INC","issuer_ticker":"ARIA","issuer_name_source":null,"issuer_url":"/issuer/0000884731","owner_cik":"0001494892","owner_name":"Haluska Frank","owner_display_name":"Haluska Frank","owner_url":"/insider/0001494892","role":"Officer (SVP, Clinical R&D, CMO)","role_mark":"O","role_mark_label":"Officer (SVP, Clinical R&D, CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Clinical R&D, CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":51000.0,"total_display":"51,000.00","total_whole":"51,000","shares_owned_after":49781.0,"shares_owned_after_display":"49,781","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-05-02","filed_date":"2012-05-04","scope":"insider"},{"id":3281395,"accession":"0001127602-12-013021","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-12-013021","line_url":"/filing/0001127602-12-013021#line-2","is_derivative":false,"issuer_cik":"0000884731","issuer_name":"ARIAD PHARMACEUTICALS INC","issuer_ticker":"ARIA","issuer_name_source":null,"issuer_url":"/issuer/0000884731","owner_cik":"0001494892","owner_name":"Haluska Frank","owner_display_name":"Haluska Frank","owner_url":"/insider/0001494892","role":"Officer (SVP, Clinical R&D, CMO)","role_mark":"O","role_mark_label":"Officer (SVP, Clinical R&D, CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Clinical R&D, CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4250.0,"shares_display":"4,250","price_per_share":16.1805,"price_display":"16.18","price_state":"stated","total_value":68767.125,"total_display":"68,767.12","total_whole":"68,767","shares_owned_after":49781.0,"shares_owned_after_display":"49,781","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-04-03","filed_date":"2012-04-03","scope":"insider"},{"id":2337448,"accession":"0001127602-12-011999","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-12-011999","line_url":"/filing/0001127602-12-011999#line-2","is_derivative":false,"issuer_cik":"0000884731","issuer_name":"ARIAD PHARMACEUTICALS INC","issuer_ticker":"ARIA","issuer_name_source":null,"issuer_url":"/issuer/0000884731","owner_cik":"0001494892","owner_name":"Haluska Frank","owner_display_name":"Haluska Frank","owner_url":"/insider/0001494892","role":"Officer (SVP, Clinical R&D, CMO)","role_mark":"O","role_mark_label":"Officer (SVP, Clinical R&D, CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Clinical R&D, CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":48000.0,"total_display":"48,000.00","total_whole":"48,000","shares_owned_after":45531.0,"shares_owned_after_display":"45,531","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-26","filed_date":"2012-03-28","scope":"insider"},{"id":2837250,"accession":"0001127602-12-011832","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-12-011832","line_url":"/filing/0001127602-12-011832#line-2","is_derivative":false,"issuer_cik":"0000884731","issuer_name":"ARIAD PHARMACEUTICALS INC","issuer_ticker":"ARIA","issuer_name_source":null,"issuer_url":"/issuer/0000884731","owner_cik":"0001494892","owner_name":"Haluska Frank","owner_display_name":"Haluska Frank","owner_url":"/insider/0001494892","role":"Officer (SVP, Clinical R&D, CMO)","role_mark":"O","role_mark_label":"Officer (SVP, Clinical R&D, CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Clinical R&D, CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6667.0,"shares_display":"6,667","price_per_share":15.4069,"price_display":"15.41","price_state":"stated","total_value":102717.8023,"total_display":"102,717.80","total_whole":"102,718","shares_owned_after":45531.0,"shares_owned_after_display":"45,531","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-23","filed_date":"2012-03-26","scope":"insider"},{"id":3281032,"accession":"0001127602-12-011602","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-12-011602","line_url":"/filing/0001127602-12-011602#line-2","is_derivative":false,"issuer_cik":"0000884731","issuer_name":"ARIAD PHARMACEUTICALS INC","issuer_ticker":"ARIA","issuer_name_source":null,"issuer_url":"/issuer/0000884731","owner_cik":"0001494892","owner_name":"Haluska Frank","owner_display_name":"Haluska Frank","owner_url":"/insider/0001494892","role":"Officer (SVP, Clinical R&D, CMO)","role_mark":"O","role_mark_label":"Officer (SVP, Clinical R&D, CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Clinical R&D, CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":15.016,"price_display":"15.02","price_state":"stated","total_value":225240.0,"total_display":"225,240.00","total_whole":"225,240","shares_owned_after":38865.0,"shares_owned_after_display":"38,865","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-20","filed_date":"2012-03-21","scope":"insider"},{"id":2484492,"accession":"0001127602-12-007664","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-12-007664","line_url":"/filing/0001127602-12-007664#line-2","is_derivative":false,"issuer_cik":"0000884731","issuer_name":"ARIAD PHARMACEUTICALS INC","issuer_ticker":"ARIA","issuer_name_source":null,"issuer_url":"/issuer/0000884731","owner_cik":"0001494892","owner_name":"Haluska Frank","owner_display_name":"Haluska Frank","owner_url":"/insider/0001494892","role":"Officer (SVP, Clinical R&D, CMO)","role_mark":"O","role_mark_label":"Officer (SVP, Clinical R&D, CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Clinical R&D, CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4500.0,"shares_display":"4,500","price_per_share":14.5059,"price_display":"14.51","price_state":"stated","total_value":65276.55,"total_display":"65,276.55","total_whole":"65,277","shares_owned_after":23865.0,"shares_owned_after_display":"23,865","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-02-21","filed_date":"2012-02-23","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":21,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":21,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":21},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000884731","name":"ARIAD PHARMACEUTICALS INC","url":"/issuer/0000884731","role":"Officer (SVP, Clinical R&D, CMO)","n_filings":20,"first_seen":"2012-02-23","last_seen":"2016-03-22"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001494892","retrieved_at":"2026-08-25T15:50:13+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}